Inzolen
Recall
|
Medicines
|
01/07/2024
The marketing authorisation holder informed its customers on June 27, 2024 that the batches mentioned are being recalled due to unresolved quality issues. The risk of a possible health hazard for treated patients can be classified as insignificant. The medicinal product is authorised in Germany and placed on the market in Austria under the Austrian Act on the Import of Medicinal Products.
| Name of the medicinal product | Inzolen |
|---|---|
| Marketing authorisation number(s) | 6072873.00.00 (DE) |
| CIP code | 01267768, 01385120, 00059855 |
| Marketing authorisation holder | Dr. Franz Köhler Chemie |
| Batch number(s) | 2108817, 2127151, 2127152 |
| Classification of the recall | 2 |
| Depth of recall | Pharmacies |
| BASG reference number | INS-640.001-4811 |
Further inquiry note
Page last modified:
03/07/2024